Nuclear Medicine and Biology
Volume 38, Issue 1 , Pages 39-51, January 2011

Radiosynthesis and pre-clinical evaluation of [18F]fluoro-[1,2-2H4]choline

  • Graham Smith

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Yongjun Zhao

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet, Ltd., Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Julius Leyton

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Bo Shan

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet, Ltd., Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Quang-de Nguyen

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Meg Perumal

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • David Turton

      Affiliations

    • GE-Imanet, Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom
  • ,
  • Erik Årstad

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet, Ltd., Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Sajinder K. Luthra

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet, Ltd., Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Edward G. Robins

      Affiliations

    • MDx Discovery (part of GE Healthcare) at Hammersmith Imanet, Ltd., Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
  • ,
  • Eric O. Aboagye

      Affiliations

    • Comprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 208 383 3759; fax: +44 208 383 1783.

Received 19 May 2009; received in revised form 14 June 2010; accepted 14 June 2010. published online 02 September 2010.

Abstract 

Introduction

Choline radiotracers are widely used for clinical PET diagnosis in oncology. [11C]Choline finds particular utility in the imaging of brain and prostate tumor metabolic status, where 2-[18F]fluoro-2-deoxy-d-glucose (‘FDG’) shows high background uptake. More recently we have extended the clinical utility of [11C]choline to breast cancer where radiotracer uptake correlates with tumor aggressiveness (grade). In the present study, a new choline analog, [18F]fluoro-[1,2-2H4]choline, was synthesized and evaluated as a potential PET imaging probe.

Methods

[18F]Fluorocholine, [18F]fluoro-[1-2H2]choline and [18F]fluoro-[1,2-2H4]choline were synthesized by alkylation of the relevant precursor with [18F]fluorobromomethane or [18F]fluoromethyl tosylate. Radiosynthesis of [18F]fluoromethyl tosylate required extensive modification of the existing method. [18F]Fluorocholine and [18F]fluoro-[1,2-2H4]choline were then subjected to in vitro oxidative stability analysis in a chemical oxidation model using potassium permanganate and an enzymatic model using choline oxidase. The two radiotracers, together with the corresponding di-deuterated compound, [18F]fluoro-[1-2H2]choline, were then evaluated in vivo in a time-course biodistribution study in HCT-116 tumor-bearing mice.

Results

Alkylation with [18F]fluoromethyl tosylate proved to be the most reliable radiosynthetic route. Stability models indicate that [18F]fluoro-[1,2-2H4]choline possesses increased chemical and enzymatic (choline oxidase) oxidative stability relative to [18F]fluorocholine. The distribution of the three radiotracers, [18F]fluorocholine, [18F]fluoro-[1-2H2]choline and [18F]fluoro-[1,2-2H4]choline, showed a similar uptake profile in most organs. Crucially, tumor uptake of [18F]fluoro-[1,2-2H4]choline was significantly increased at late time points compared to [18F]fluorocholine and [18F]fluoro-[1-2H2]choline.

Conclusions

Stability analysis and biodistribution suggest that [18F]fluoro-[1,2-2H4]choline warrants further in vivo investigation as a PET probe of choline metabolism.

Keywords: Choline, Fluorocholine, Choline kinase, Fluorine-18, Isotope effect, Quantum tunneling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding provided by CR-UK&EPSRC Cancer Imaging Centre at Imperial College, London, in association with the MRC and Department of Health (England) grant C2536/A10337 and UK Medical Research Council core funding grant U.1200.02.005.00001.01.

PII: S0969-8051(10)00325-2

doi:10.1016/j.nucmedbio.2010.06.012

Nuclear Medicine and Biology
Volume 38, Issue 1 , Pages 39-51, January 2011